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Background: Supplemental O2 is often administered without knowledge
of CO2 levels for patients with ventilatory pump failure (VPF). This can
render oximetry ineffective as a gauge of alveolar ventilation, airway
secretions, and lung disease. We have noted that diurnal hypoventilation
with hypercapnia tends to be symptomatic when O2 saturation levels
decrease below 95% and patients extend sleep noninvasive ventilatory
support (NVS) into daytime hours. We also noted that with advancing
age, less hypercapnia results in desaturation. This study was designed to
explore oxyhemoglobin desaturations (O2 desats) as a function of age
and hypercapnia for patients with VPF.
Methods: A retrospective analysis of 8933 consecutive patient visits for
whom end‐tidal CO2 and O2 sats were measured. O2 sats < 95% at CO2
levels of 45, 50, and 60 cmH2O were correlated with 10 years age inter‐
vals to age 80.
Results: Of 8933 visits, 8642 had complete data. Outcomes for CO2
levels > 50 cmH2O were the most significant including for visit‐ages < 30
and ≥ 30 years. There was a statistically significant 4% decrease in the
odds of O2 desat for every one‐year increase in age to age 30 (OR = 0.96,
95% CI = [0.93, 0.99], p = 0.02) and for visit‐ages ≥ 30 a significant 30%
increase in the odds of O2 desat for every 10‐year increase in age (OR 1.3,
95% CI = [1.1, 1.6], p = 0.006). Relationship for ages ≥ 30 years were also
significant for CO2 levels over 45 mmHg also. 40% of the time when CO2
was greater than 45 mmHg O2 sat was low.
Discussion: This study demonstrated a significantly lower risk of O2
desat occurring at EtCO2 levels ≥ 50 mmHg for patients from 10 to 20
years of age than those younger than 10 and a significantly greater risk
of O2 desat for 10 years intervals after age 20. Thus, with age, less
hypercapnia results in desats and dyspnea with patients tending to
extend NVS into daytime hours. This may be due to increases in
physiological shunting, decreased pulmonary elasticity, and worsening
ventilation/perfusion ratios with age.
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Introduction

Over the course of 8642 visits of patients with
ventilatory pump failure (VPF), most of whom
with neuromuscular diseases (NMDs), older
patients appeared to develop oxyhemoglobin
saturation (O2 sat) below 95% at lower levels of
hypercapnia. It also became apparent that
symptoms of hypoventilation and resort to
daytime noninvasive ventilatory support (NVS),
paralleled decreases in O2 sat below 95% irre‐
spective of extent of daytime hypercapnia. We
undertook this study to determine age related
O2 desat as a function of end‐tidal CO2 levels
(EtCO2).
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Materials and methods

We performed a retrospective review of all visits
of patients with VPF for whom end‐tidal CO2
and O2 sats were measured simultaneously and
the data taken from the database of patient visits
to a NMD clinic. All CO2 and O2 sat measurements
were obtained by the same therapist over a 35
year period. The highest observed EtCO2 was
recorded. For patients with very shallow tidal
volumes, an abdominal thrust was applied at
end expiratory to obtain an end‐tidal sample.
Since all patients had normal PetCO2 and O2 sat
levels while using NVS, their data did not
contribute to the analyses in this study. No
patients received supplemental O2. All measure‐
ments were made with the patients sitting and
at routine out‐patient visits.
We excluded patients for whom EtCO2, O2 sat,
or age were lacking. The maximum observed
EtCO2 and maximum and minimum visit O2 sat
data were recorded with the minimum O2 sat
used for this analysis. The minimum O2 sat data
were then segregated as a function of age in 10
year groupings for EtCO2 levels of 45, 50, and 60
mmHg. The database for this study terminated
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in July 2017 when all medical records were
mandated to be input into a standard electronic
medical records system from which the data
were no longer readily accessible electronically.
We screened for the following symptoms of
hypoventilation: fatigue, daytime drowsiness,
morning headaches, respiratory orthopnea, diffi‐
culty concentrating, and others [1], diagnosis, and
for extent of use of NVS. When symptoms were
associated with vital capacities (VC) diminished
by 30% or more from predicted normal levels or
by hypercapnia (EtCO2 > 45 mmHg) with or
without O2 sat < 95%, sleep NVS was offered at
full NVS settings to optimally rest respiratory
muscles and provide NVS as needed rather than
use “NIV”, that is, noninvasive ventilation or
bi‐level positive airway pressure at less than
NVS settings [1]. The subsequent effects on
daytime O2 sat and CO2 were observed. Patients
were encouraged to use sleep NVS only if their
symptoms were relieved by it otherwise they
would be reevaluated at future visits.
The NVS settings were typically volume
preset assist‐control range 700 to 1500 ml and
rate 12–14 as per patient preference. Over 80% of
NVS users chose to use 1200 to 1300 ml volumes.
The NVS users were typically switched to
pressure assist/control settings of 17–25 cmH2O
if abdominal distention became a problem.
Patients with morbid obesity, however, typically
used sleep as well as at least some daytime NVS
at positive inspiratory pressures (PIPs) between
25 and 55 cmH2O. The NVS settings were
intended to optimize respiratory muscle rest and
maintain normal CO2 and O2 sat levels during
sleep and as normal as possible when not using
NVS during daytime hours. O2 sat and CO2
levels were always normal while using NVS
during daytime hours such as for continuous
noninvasive ventilatory support (CNVS) users
with little or no ventilator free breathing ability.
We used generalized estimating equations
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with a logistic link and binomial distribution to
model the relationship between age groups and
O2 values < 95%. The robust “sandwich” esti‐
mator, shown to be sufficient in larger studies,
was used to estimate the standard error [2]. We
stratified the analysis on patient age and
estimated the trend in the proportion of O2
values falling short of 95% (O295) as a function
of age for CO2 exceeding 45, 50, and 60 mmHg.
Results are presented as odds ratios (OR) and
95% confidence intervals (CI). A 95% CI that
excludes the value 1.0 is equivalent to a p‐value
< 0.05 (statistical significance).

wall deformity/coliosis, 47; morbid obesity, 27;
other neurological disease (OND) including mul‐
tiple sclerosis, cerebral palsy, and traumatic
brain injury, 80. The number of data points per
patient ranged from 1 to 23 with 60% of subjects
contributing 1, and 15% 2 points. Thirty‐six
percent of the points were from subjects aged 30
years or younger at first visit. There were 1483
data points for CO2 ≥ 45 mmHg. All patients
other than the majority of ALS patients used
only NVS rather than tracheostomies for ventila‐
tory support.
Considering the three CO2 values of 45, 50,

3

Results

and 60 mmHg and the relationship between age
and SpO2 < 95% for 10‐year age intervals below

Of 8833 patient visits, 4968 from males, 3865
females, 8642 had demographic data and
measurements of O2 sat and EtCO2. Incomplete
data resulted in the exclusion of 133 additional
data points. There were 1453 points of data with
EtCO2 ≥ 45 mmHg and 583 of these with O2
sat < 95%. Fig. 1 is a patient flow diagram. The
8509 studied data points were from 3095 patients
with the following diagnoses: Duchenne muscular
dystrophy (DMD), 279; non‐DMD myopathies, 289;
spinal muscular atrophy (SMA) type 1, 235;
other SMAs, 327; amyotrophic lateral sclerosis/
motor neuron disease (ALS), 569; myotonic
dystrophy, 177; other NMDs (OMD), 1301; high
level spinal cord injury (SCI), 80; severe chest

and above ages 20 and 30 (Table 1) the only
statistically

significant

relationship

for the

intervals below age 30 was for O2 desaturation
occuring for EtCO2 ≥ 50 mmHg (p < 0.02).
However, for the 10‐year age intervals greater
than age 20, O2 desaturation below 95% was
very significantly more likely for the intervals
when EtCO2 ≥ 45 mmHg, as well as ≥ 50 mmHg
(Table 1). Restricting the analysis to subjects
with all CO2 values exceeding 50 mmHg for
visit‐ages < 30 and ≥ 30 years, there was a

statistically significant 4% decrease in the odds
of O2 desat for every 1‐year increase in age to
age 30 (OR = 0.96, 95% CI = [0.93, 0.99], p = 0.02)
and for visit‐ages ≥ 30 there was a significant
30% increase in the odds of O2 desat for every
10‐year increase in age (OR 1.3, 95% CI = [1.1,
1.6], p = 0.006).
Restricting the analysis to subjects with all
CO2 values exceeding 60 mmHg, there was no
significant change in the odds of O2 desat for
either age‐visit groups but for age < 30, for every
one‐year increase in age, there is a 7% not statis‐
tically significant decline in O2 desat (p = 0.08, OR =

Fig. 1

Respiratory data flow diagram.

0.93, 95% CI = [0.86, 1.001]). For persons aged ≥ 30
Journal of Neurorestoratology
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Odds ratios stratified by age‐at‐visits for CO2 ≥ 45, 50, and 60 mmHg with oxyhemoglobin saturation levels less than 95%.
Pivoting on age 20 years
Under 20 years of age*

20 years of age and older**

CO2 values
(mmHg)

Number of
visits

OR (95% CI)

p‐value

≥ 45

1453

0.96 (0.91, 1.01)

≥ 50

664

≥ 60

121

OR (95% CI)

p‐value

0.11

1.34 (1.2, 1.5)

< 0.0001

0.97 (0.92, 1.02)

0.26

1.41 (1.2, 1.6)

< 0.0001

0.91 (0.81, 1.02)

0.09

1.2 (0.8, 1.8)

0.39

Pivoting on age 30 years
Under 30 years of age*

30 years of age and older**

CO2 values
(mmHg)

Number of
visits

OR (95% CI)

p‐value

OR (95% CI)

p‐value

≥ 45

1453

0.98 (0.94, 1.01)

0.18

1.22 (1.03, 1.45)

0.02

≥ 50

664

0.96 (0.93, 0.99)

0.02

1.3 (1.1, 1.6)

0.006

≥ 60

121

0.93 (0.86, 1.01)

0.08

0.98 (0.63, 1.54)

0.94

OR, odds ratio.
* OR associated with a 1‐year increase in age; ** OR associated with a 10‐year increase in age.

years, there is a not statistically significant 2%
decrease in the odds of O2 desat for every
10‐year increase in age (p = 0.94, OR = 0.98, 95%
CI = [0.63, 1.54]).
Table 2 demonstrates the numbers of patients
with minimum daytime O2 sat levels below 95%
for 10‐year age intervals through age 80 for
EtCO2 levels ≥ 45, 50, and 60 mmHg, respec‐
tively. Tables 1 and 2 and Fig. 2 demonstrate the
tendencies to have O2 desaturation occur with
hypercapnia of 45, 50, and 60 mmHg for 10‐year
age intervals.
All 3095 patients eventually began requiring
Table 2

sleep NVS with or without having normal
daytime blood gases. Initially, except for five
morbidly obese patients, the daytime O2 sat and
EtCO2 were completely normalized by sleep
NVS. Over 1000 of these patients including all
279 with DMD, 45% of those with ALS/MND, all
with SMA type 1, over 100 with congenital
myopathies, 5 high level SCI patients and 15
with morbid obesity eventually became CNVS
dependent with little or no ventilator free
breathing ability. Nine of the SMA type 1
patients are now over 20 years of age with VCs
as little as 0 and CNVS dependent from as

O2 saturation levels less than 95% for patients with end‐tidal CO2 levels greater than or equal to 45, 50, and 60 mmHg.
< 10
years

11–20
years

21–30
years

31–40
years

41–50
years

51–60
years

61–70
years

71–80
years

Overall

EtCO2 ≥
45 mmHg
Sat O2 < 95%

28
(41.2%)

61
(26.1%)

52
(23.3%)

111
(43.7%)

97
(44.3%)

97
(43.9%)

82
(51.3%)

55
(73.3%)

583
(40.1%)

EtCO2 ≥
50 mmHg
Sat O2 < 95%

23
(60.5%)

40
(44.4%)

38
(37.6%)

73
(59.8%)

60
(57.1%)

62
(62.4%)

51
(72.9%)

33
(84.6%)

380
(57.2%)

EtCO2 ≥
60 mmHg
Sat O2 < 95%

8
(100%)

15
(78.9%)

15
(71.4%)

26
(89.7%)

12
(66.7%)

9
(81.8%)

10
(90.9%)

33
(84.6%)

99
(81.8%)

Age
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Fig. 2 Percentage of O2 desaturation (< 95%) as a function of age for end-tidal CO2 greater than or equal to 45 mmHg.

young as 4 months of age but all these and all
the other patients including all with morbid
obesity maintained normal CO2 and O2 sat levels
while actually using NVS/CNVS, that is, end‐
tidal CO2 ≤ 42 mmHg and O2 sat ≥ 95% in
ambient air.

4

Discussion

This study demonstrated a significantly lower
risk of O2 desat occurring at EtCO2 levels
≥ 50 mmHg for patients from 10 to 20 years of
age than for patients younger than age 10 and a
significantly greater risk of increasingly severe
O2 desat occurring after 20 years of age for
patients with EtCO2 ≥ 45, and ≥ 50 mmHg.
Specifically, O2 desat occurred for significantly
fewer patients at CO2 levels of 50 mmHg for the
second 10‐year interval (ages 10 to 20) than the
first interval and then occurred for an increasingly
higher percentage of patients at 45 and 50 cmH2O
for every 10‐year interval subsequently. EtCO2 is
reported to reflect PaCO2 levels to an accuracy of 1
to 2 mmHg [3].
We observed that virtually all of the patients
using sleep NVS who extended it into daytime
hours did so only after daytime hypercapnia
was associated with dips in O2 sat below 95%.

Subsequently patients required NVS increa‐
singly into daytime hours, in many cases to
become CNVS dependent with little to no
ventilator free breathing ability. Over 250 of
these patients also required extubation back to
CNVS during intercurrent episodes of acute
respiratory failure (ARF) and thereby avoided
tracheotomies [4, 5]. There is no comparable
medical literature on this subject.
Alveolar hypoventilation signaled by hyper‐
capnia is a common cause of oxyhemoglobin
desaturation in these patients. Airway secretion
congestion and intrinsic lung disease also cause
hypoxia but may not be associated with
hypercapnia. Oxygen supplementation to treat
hypoxia can severely exacerbate CO2 retention,
it does not treat the underlining cause of the
hypoxia and often results in ARF and intubation,
so O2 supplementation should not be used as a
substitute for NVS and mechanical inexsuff‐
lation (MIE) to clear airway secretions for these
patients [6].
In this study, 59.9% of the time when EtCO2
was greater than 45 mmHg, O2 sat was normal.
This included 18.2% of instances when EtCO2
was greater than 60 mmHg. While the association
of hypoxia secondary to hypoventilation and
hypercapnia is clear, and that O2 supplementation
Journal of Neurorestoratology
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exacerbates CO2 retention via the Haldane effect
and diminution of hypoxic ventilatory drive, the
role of hypercapnia in the mechanism of
hypoxemia is unclear. Apparently, tolerance of
hypercapnia, 59.9% in the early years, decreases
with age as shown in Fig. 2. Why this occurs is
unclear. Age is linked to the development and
growth of the lungs and cardiovascular system.
The alveolarization stage, when new alveoli and
bronchioles are forming, ends around age 3.
Around that time alveolar microvasculature
matures, decreasing the thickness of the alveolar
walls [7–10]. Up to 8 years of age, alveoli increase
in number and size and do so through age 18 [8].
In turn, pulmonary mechanics change. A new
born child’s airway resistance can be 15 times
greater than for adults [7, 8]. Vital capacity
peaks at 19 to 20 years of age then decreases at
1% to 1.2% per year. Thus, at about 20 years of
age the respiratory system is at its peak.
With age there are increases in physiological
shunting, decreased pulmonary elasticity, and
worsening ventilation/perfusion ratios. Respiratory
muscle weakness increases residual volume,
increases the alveolar arterial oxygen difference
(DA‐aO2), and PaO2 and VC also decrease with
age [11–19]. Thus, for PaO2 of 100 mmHg, pulse
oximetry is normally above 95% and remains
normal even if PaO2 decreases by 20 mmHg
or more for a physiological “cushion” for
adolescents. However, with age the greater
arterial‐oxygen difference (DA‐aO2) decreases
PaO2 and milder hypercapnia results in O2
desat.
Limitations of this study include that BMIs
were not recorded. Although smoking histories
were obtained, so few of these patients smoked
or were able to bring cigarettes to their mouths
that these data were not tabulated. Co‐mor‐
bidities were not taken into account other than
to exclude cardiac causes of any hypoxia. There
was also a wide range of data points per subject.
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Another limitation stems from the fact that for
normals, awake PetCO2 differs from PaCO2 by
only 1 to 2 mmHg [3]. However, even for normal
subjects, tidal volumes decrease during sleep,
the ratio of dead space to tidal volume increases,
and patients can exhale out of the mouth and
thereby bypass the PetCO2 sampling at the
nostrils and render PetCO2 falsely low. PetCO2 is
also less accurate in the presence of high PaCO2
levels [20]. On the other hand, many studies
have reported PetCO2 to be accurate for
conditions in which the exhaled gas can be
sampled within or close to the airways such as
for patients whose alveolar dead space is not
very large and, if using NIV/NVS, for those
whose sampling is at the prongs, as in these
cases, rather than via larger interfaces that dilute
the sample [21]. In a study of 39 subjects with
NMD, while maximum transcutaneous (Ptc)
CO2 was 4 to 16 mmHg higher than EtCO2s,
mean PtcCO2s was less than 1 mmHg to 7
mmHg greater [22]. This discrepancy could
change the threshold in the correlation of O2
desaturation as a function of age and CO2 levels
but it does not change the fact that the aging
patient is more likely to have O2 desaturation at
lower levels of hypercapnia.
The greater the capacity to incorporate O2 in
hemoglobin, the greater the hypercapnia to‐
lerated by the organism without the appearance
of hypoxemia. Very young patients, whose
lungs are still developing, and old patients have
the least capacity to tolerate hypoventilation
without producing hypoxemia. The process by
which hypoventilation generates hypoxemia is
dynamic and not only depends on increases in
CO2 but also on respiratory capacity and PaO2
that changes with each stage of pulmonary
development. Further study is needed to better
understand these phenomena.
In conclusion, the mission of neurorestoratology
includes maximizing the physical functioning of
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patients impaired by NMD whose activities of
daily living are greatly restricted by dyspnea
and the other neurological symptoms of hyper‐
capnia. The use of NVS can relieve these
symptoms and, when extended to CNVS,
permits lifetime ventilatory support without
resort to invasive airway tubes and invasive
mechanical ventilation. It can both extend life
and preserve quality of life by restoring the
patients’ ability to function to the level permi‐
tted by only their skeletal muscle, but not their
respiratory muscle, impairment.
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